×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Nanotechnology: Application to Medical Products
Session Chair(s)
Suzanne Sensabaugh, MBA, MS
President and Principal Consultant
HartmannWillner LLC, United States
This session will address the topic of nanotechnology with a focus on its use for drugs and biologics. It will define the term; provide a basic overview of the technology and uses; and address development, scientific, and regulatory challenges.
Learning Objective : Define nanotechnology; Explain the application of nanotechnology as it relates to drugs and biologics; Describe the current landscape of medical products in development; Enumerate development, scientific, and regulatory challenges; Identify the preclinical and clinical requirements.
Speaker(s)
Biomedical Nanotechnology: The Smaller the Thing, the Bigger the Challenge
Michael Drues, PhD
Vascular Sciences, United States
Founder and President
Nanomaterials in Drug Products: A Regulatory Update
Celia N. Cruz, PhD
FDA, United States
Senior Product Quality Reviewer, OPS, CDER
Industry Perspectives of Nanomedicines: It's a Small World After All
Frank J Malinoski, MD, PhD
Liquidia Technologies, United States
Chief Medical Officer
Have an account?